HRT Financial’s Applied Therapeutics APLT Stock Holding History

HRT Financial’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-94,870	Closed	-$57K	–	3134
2025 Q3	$57K	Buy	94,870 +39,655	+72%	+$18.7K	﹤0.01%	2588
2025 Q2	$17K	Buy	+55,215	New	+$21.4K	﹤0.01%	2413
2025 Q1	–	Sell	-242,878	Closed	-$207K	–	2488
2024 Q4	$207K	Buy	+242,878	New	+$1.52M	﹤0.01%	1921
2024 Q2	–	Sell	-98,879	Closed	-$672K	–	2182
2024 Q1	$672K	Buy	+98,879	New	+$444K	﹤0.01%	1099
2023 Q4	–	Sell	-11,852	Closed	-$29K	–	2281
2023 Q3	$29K	Buy	+11,852	New	+$19.5K	﹤0.01%	2039
2022 Q4	–	Sell	-28,380	Closed	-$26K	–	2439
2022 Q3	$26K	Sell	28,380 -115,906	-80%	-$139K	﹤0.01%	2472
2022 Q2	$136K	Buy	144,286 +95,549	+196%	+$156K	﹤0.01%	2359
2022 Q1	$102K	Buy	+48,737	New	+$131K	﹤0.01%	2654

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HRT Financial's APLT Position: Q4 2025 in Review

HRT Financial sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 94,870 shares — an estimated $57K sold.

HRT Financial first reported a position in APLT in Q1 2022 and held it in 8 quarters. The position peaked at $672K in Q1 2024. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

HRT Financial reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 94,870 Applied Therapeutics shares in Q4 2025, an estimated $57K.
HRT Financial first reported a position in Applied Therapeutics in Q1 2022 and held it in 8 quarters.
HRT Financial's Applied Therapeutics position peaked at $672K in Q1 2024.
52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.